Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 years or older.
- People who have been diagnosed with prediabetes according to American Diabetes Association guidelines.
- People who are managing their prediabetes with diet and exercise only, or with a stable dose of metformin taken for at least 3 months before the study begins.
- People who are able to follow the study's requirements and keep a patient diary throughout the trial.
- People who have provided signed consent to participate.
Who may not be able to join:
- People who have been diagnosed with type 1 or type 2 diabetes.
- People with serious liver or kidney disease that is not well controlled (confirm with trial site regarding specific kidney function levels).
- People who have had a significant heart-related event in the past 12 months — such as a heart attack, major irregular heartbeat, unstable chest pain, or heart bypass surgery — or who are expected to need such procedures during the study.
- People with certain hormone or gland conditions, such as Cushing's syndrome or acromegaly, that affect blood sugar levels.
- People who are pregnant or breastfeeding.
- People with mental health or cognitive conditions that would make it difficult to take part in the study.
- People who have used any form of steroid medication (by mouth, inhaled, or injected) on a daily basis in the past 3 months.
- People who have used a continuous glucose monitoring (CGM) device at any point in the past 12 months.
- People with a known allergy to sensor materials.
- People with a current or past substance or alcohol use problem that, in the opinion of the study investigators, could affect their ability to follow study requirements.
- People who have taken part in another clinical trial within the last 3 months.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nazarii Kobyliak, Bogomolets National Medical University
Phone: +380442356005
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Changes in HbA1c level; Changes in Fructosamine level
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.